Skip to main content
Clinical Trials/NCT03769493
NCT03769493
Completed
N/A

Mobile After-Care Support Intervention for Patients With Schizophrenia Following Hospitalization (MACS)

Butler Hospital1 site in 1 country10 target enrollmentJanuary 16, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Psychotic Disorders
Sponsor
Butler Hospital
Enrollment
10
Locations
1
Primary Endpoint
Client Satisfaction Questionnaire (CSQ)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study examines the feasibility and acceptability of a mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder.

Detailed Description

In the open trial, all participants will receive a study-developed app to be used on a mobile phone. This app will support the use of healthy coping skills post-hospitalization, as well as help participants adhere to their discharge treatment plan. This phase is intended to inform the feasibility and acceptability of the app in preparation for a future randomized controlled trial.

Registry
clinicaltrials.gov
Start Date
January 16, 2019
End Date
October 15, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Brandon Gaudiano

Research Psychologist

Butler Hospital

Eligibility Criteria

Inclusion Criteria

  • Currently hospitalized
  • DSM-5 criteria for psychotic disorder (schizophrenia or schizoaffective disorder)
  • 18 years or older
  • Prescribed oral antipsychotic medication upon discharge
  • Ability to speak and read English

Exclusion Criteria

  • Alcohol/drug use disorders at moderate or severe level
  • Planned discharge to supervised living setting or participation in formal outpatient adherence programs (e.g., medication packaging)
  • Pregnancy or other medical condition (e.g., dementia) contraindicating use of antipsychotic medications.

Outcomes

Primary Outcomes

Client Satisfaction Questionnaire (CSQ)

Time Frame: 1 month

The Client Satisfaction Questionnaire is a self-report measure of patient satisfaction with treatment. The total score will be used and ranges from 8 to 32 with increased scores indicating greater satisfaction with treatment.

Secondary Outcomes

  • Brief Adherence Rating Scale (BARS)(1 month)
  • Brief Psychiatric Rating Scale (BPRS)(1 month)
  • Maastricht Assessment of Coping Strategies (MACS)(1 month)

Study Sites (1)

Loading locations...

Similar Trials